| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-74793 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-77071-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-72294 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-77187-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-41166-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-77125-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-64650-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76542-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76946-0.025mg | |||
![Western Blot: u-Plasminogen Activator/Urokinase Antibody (5H4) [NBP2-46436] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY u-Plasminogen Activator.](http://images.novusbio.com/fullsize/u-Plasminogen-Activator-Urokinase-Antibody-5H4-Western-Blot-NBP2-46436-img0005.jpg "Western Blot: u-Plasminogen Activator/Urokinase Antibody (5H4) [NBP2-46436] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY u-Plasminogen Activator.")
![Immunohistochemistry: u-Plasminogen Activator/Urokinase Antibody (5H4) [NBP2-46436] - Analysis of Carcinoma of Human pancreas tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/u-Plasminogen-Activator-Urokinase-Antibody-5H4-Immunohistochemistry-NBP2-46436-img0004.jpg)
![Immunohistochemistry: u-Plasminogen Activator/Urokinase Antibody (5H4) [NBP2-46436] - Analysis of Adenocarcinoma of Human colon tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/u-Plasminogen-Activator-Urokinase-Antibody-5H4-Immunohistochemistry-NBP2-46436-img0001.jpg)
![Immunohistochemistry: u-Plasminogen Activator/Urokinase Antibody (5H4) [NBP2-46436] - Analysis of Carcinoma of Human lung tissue.(Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/u-Plasminogen-Activator-Urokinase-Antibody-5H4-Immunohistochemistry-NBP2-46436-img0002.jpg)
![Immunohistochemistry: u-Plasminogen Activator/Urokinase Antibody (5H4) [NBP2-46436] - Analysis of Human pancreas tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/u-Plasminogen-Activator-Urokinase-Antibody-5H4-Immunohistochemistry-NBP2-46436-img0003.jpg)
![Western Blot: JMJD1B Antibody [NBP1-77071] - Rat liver tissue lysate with JMJD1B antibody at (A) 1 and (B) 2 ug/ml.](http://images.novusbio.com/fullsize/JMJD1B-Antibody-Western-Blot-NBP1-77071-img0002.jpg "Western Blot: JMJD1B Antibody [NBP1-77071] - Rat liver tissue lysate with JMJD1B antibody at (A) 1 and (B) 2 ug/ml.")
![Immunocytochemistry/ Immunofluorescence: JMJD1B Antibody - BSA Free [NBP1-77071] - Immunofluorescence of JMJD1B in rat liver tissue with JMJD1B antibody at 20 u/mL.](http://images.novusbio.com/fullsize/nbp1-77071_rabbit-polyclonal-jmjd1b-antibody-2711202420441156.jpg)
![Immunohistochemistry: JMJD1B Antibody - BSA Free [NBP1-77071] - Immunohistochemistry of JMJD1B in rat liver tissue with JMJD1B antibody at 2.5 u/mL.](http://images.novusbio.com/fullsize/nbp1-77071_rabbit-polyclonal-jmjd1b-antibody-2711202419251565.jpg)
![Western Blot: ECRG4 Antibody (3B10) [NBP2-00599] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY ECRG4 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-ECRG4.](http://images.novusbio.com/fullsize/ECRG4-Antibody-3B10-Western-Blot-NBP2-00599-img0008.jpg "Western Blot: ECRG4 Antibody (3B10) [NBP2-00599] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY ECRG4 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-ECRG4.")
![Immunocytochemistry/Immunofluorescence: ECRG4 Antibody (3B10) [NBP2-00599] - Immunofluorescent staining of HeLa cells using anti-ECRG4 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/ECRG4-Antibody-3B10-Immunocytochemistry-Immunofluorescence-NBP2-00599-img0007.jpg)
![Flow Cytometry: ECRG4 Antibody (3B10) [NBP2-00599] - Analysis of Jurkat cells, using anti-ECRG4 antibody, (Red), compared to a nonspecific negative control antibody (Blue).](http://images.novusbio.com/fullsize/ECRG4-Antibody-3B10-Flow-Cytometry-NBP2-00599-img0006.jpg)
![Flow Cytometry: ECRG4 Antibody (3B10) [NBP2-00599] - Analysis of Hela cells, using anti-ECRG4 antibody, (Red), compared to a nonspecific negative control antibody (Blue).](http://images.novusbio.com/fullsize/ECRG4-Antibody-3B10-Flow-Cytometry-NBP2-00599-img0005.jpg)
![Immunohistochemistry-Paraffin: Secernin-1 Antibody [NBP1-77187] - Human kidney tissue with Secernin-1 antibody at 5 ug/mL.](http://images.novusbio.com/fullsize/Secernin-1-Antibody-Immunohistochemistry-Paraffin-NBP1-77187-img0002.jpg "Immunohistochemistry-Paraffin: Secernin-1 Antibody [NBP1-77187] - Human kidney tissue with Secernin-1 antibody at 5 ug/mL.")
![Immunocytochemistry/ Immunofluorescence: Secernin-1 Antibody - BSA Free [NBP1-77187] - Immunofluorescence of Secernin-1 in Human Kidney cells with Secernin-1 antibody at 20 ug/mL.](http://images.novusbio.com/fullsize/nbp1-77187_rabbit-polyclonal-secernin-1-antibody-2711202419333485.jpg)
![<b>Biological Strategies Validation. </b>Western Blot: Secernin-1 Antibody - BSA Free [NBP1-77187] - Western blot analysis of SCRN1 in human kidney tissue lysate with SCRN1 antibody at 1 ug/mL in (A) the absence and (B) the presence of blocking peptide.](http://images.novusbio.com/fullsize/antibody/nbp1-77187_rabbit-polyclonal-secernin-1-antibody-western-blot-1192024171326.jpg)
![Western Blot: AIG1 Antibody [NBP2-41166] - Western blot analysis of AIG1 in human brain tissue lysate with AIG1 antibody at (A) 1 and (B) 2 ug/mL.](http://images.novusbio.com/fullsize/AIG1-Antibody-Western-Blot-NBP2-41166-img0001.jpg "Western Blot: AIG1 Antibody [NBP2-41166] - Western blot analysis of AIG1 in human brain tissue lysate with AIG1 antibody at (A) 1 and (B) 2 ug/mL.")
![Immunocytochemistry/Immunofluorescence: AIG1 Antibody [NBP2-41166] - Immunofluorescence of AIG1 in human brain tissue with AIG1 antibody at 20 ug/mL.](http://images.novusbio.com/fullsize/AIG1-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-41166-img0003.jpg)
![Immunohistochemistry: AIG1 Antibody - BSA Free [NBP2-41166] - Immunohistochemistry of AIG1 in human brain tissue with AIG1 antibody at 2.5 ug/mL.](http://images.novusbio.com/fullsize/nbp2-41166_rabbit-polyclonal-aig1-antibody-2711202420405592.jpg)
![Western Blot: Breast carcinoma amplified sequence 3 Antibody [NBP1-77125] - Rat brain tissue lysate with BCAS3 antibody at (A) 0.5 and (B) 1 ug/ml.](http://images.novusbio.com/fullsize/Breast-carcinoma-amplified-sequence-3-Antibody-Western-Blot-NBP1-77125-img0001.jpg "Western Blot: Breast carcinoma amplified sequence 3 Antibody [NBP1-77125] - Rat brain tissue lysate with BCAS3 antibody at (A) 0.5 and (B) 1 ug/ml.")
![Immunocytochemistry/ Immunofluorescence: Breast carcinoma amplified sequence 3 Antibody - BSA Free [NBP1-77125] - Immunofluorescence of Breast carcinoma amplified sequence 3 in human breast carcinoma tissue with Breast carcinoma amplified sequence 3 antibody at 20 u/mL.](http://images.novusbio.com/fullsize/nbp1-77125_rabbit-polyclonal-breast-carcinoma-amplified-sequence-3-antibody-271120242016931.jpg)
![Immunohistochemistry: Breast carcinoma amplified sequence 3 Antibody - BSA Free [NBP1-77125] - Immunohistochemistry of Breast carcinoma amplified sequence 3 in human breast carcinoma with Breast carcinoma amplified sequence 3 antibody at 5 ug/mL.](http://images.novusbio.com/fullsize/nbp1-77125_rabbit-polyclonal-breast-carcinoma-amplified-sequence-3-antibody-2711202420141939.jpg)
![Western Blot: BCL9-2 Antibody [NBP1-76542] - HeLa cell lysate at 1 ug/mL in (A) the absence and (B) the presence of blocking peptide.](http://images.novusbio.com/fullsize/BCL9-2-Antibody-Western-Blot-NBP1-76542-img0004.jpg "Western Blot: BCL9-2 Antibody [NBP1-76542] - HeLa cell lysate at 1 ug/mL in (A) the absence and (B) the presence of blocking peptide.")
![Immunocytochemistry/ Immunofluorescence: BCL9-2 Antibody - BSA Free [NBP1-76542] - Immunofluorescence of BCL9-2 in human breast tissue with BCL9-2 antibody at 20 ug/ml.Green: BCL9-2 Antibody Blue: DAPI staining](http://images.novusbio.com/fullsize/nbp1-76542_rabbit-polyclonal-bcl9-2-antibody-2711202420405548.gif)
![Immunohistochemistry: BCL9-2 Antibody [NBP1-76542] - Staining of Bcl9L in human breast tissue with Bcl9L antibody at 5 ug/ml.](http://images.novusbio.com/fullsize/BCL9-2-Antibody-Immunohistochemistry-NBP1-76542-img0006.jpg)
![Immunocytochemistry/ Immunofluorescence: BCL9-2 Antibody - BSA Free [NBP1-76542] - Immunocytochemistry of BCL9-2 in HeLa cells with BCL9-2 antibody at 10 ug/mL.](http://images.novusbio.com/fullsize/nbp1-76542_rabbit-polyclonal-bcl9-2-antibody-27112024204564.jpg)
![Western Blot: CUEDC1 Antibody [NBP1-76946] - Rat liver tissue lysate with CUEDC1 antibody at (A) 0.5 and (B) 1 ug/ml.](http://images.novusbio.com/fullsize/CUEDC1-Antibody-Western-Blot-NBP1-76946-img0002.jpg "Western Blot: CUEDC1 Antibody [NBP1-76946] - Rat liver tissue lysate with CUEDC1 antibody at (A) 0.5 and (B) 1 ug/ml.")
![Immunocytochemistry/ Immunofluorescence: CUEDC1 Antibody - BSA Free [NBP1-76946] - Immunofluorescence of CUEDC1 in human liver tissue with CUEDC1 antibody at 20 ug/mL.](http://images.novusbio.com/fullsize/nbp1-76946_rabbit-polyclonal-cuedc1-antibody-2711202420171773.jpg)
![Immunohistochemistry: CUEDC1 Antibody - BSA Free [NBP1-76946] - Immunohistochemistry of CUEDC1 in human liver tissue with CUEDC1 antibody at 2 ug/mL.](http://images.novusbio.com/fullsize/nbp1-76946_rabbit-polyclonal-cuedc1-antibody-2711202419261865.jpg)
![Western Blot: Indoleamine 2,3-dioxygenase/IDO Antibody [NB100-2459] - (0.5ug/ml) staining of Human Lymph Node (A), Spleen (B) and Placenta (C) lysates (35ug protein in RIPA buffer). Detected by chemiluminescence.](http://images.novusbio.com/fullsize/Indoleamine-2-3-dioxygenase-IDO-Antibody-Western-Blot-NB100-2459-img0007.jpg "Western Blot: Indoleamine 2,3-dioxygenase/IDO Antibody [NB100-2459] - (0.5ug/ml) staining of Human Lymph Node (A), Spleen (B) and Placenta (C) lysates (35ug protein in RIPA buffer). Detected by chemiluminescence.")
![Immunohistochemistry-Paraffin: Indoleamine 2,3-dioxygenase/IDO Antibody [NB100-2459] - Negative Control showing staining of paraffin embedded Human Placenta, with no primary antibody.](http://images.novusbio.com/fullsize/NB100-2459_Immunohistochemistry-Paraffin-Indoleamine-2-3-dioxygenase-IDO-Antibody-NB100-2459-Negative-Control-showing-staining-of-paraffin-embedded-Human-Placenta-with-no-primary-antibody--29320239254017.jpg)
![Immunohistochemistry-Paraffin: Indoleamine 2,3-dioxygenase/IDO Antibody [NB100-2459] - (6ug/ml) staining of paraffin embedded Human Placenta. Heat induced antigen retrieval with citrate buffer pH 6, HRP-staining.](http://images.novusbio.com/fullsize/NB100-2459_Immunohistochemistry-Paraffin-Indoleamine-2-3-dioxygenase-IDO-Antibody-NB100-2459-6ug-ml-staining-of-paraffin-embedded-Human-Placenta-Heat-induced-antigen-retrieval-with-citrate-buffer-pH-6-HRP-staining--29320239254031.jpg)
![Western Blot: EWSR1 Antibody [NBP1-28798] - (0.3ug/ml) staining of nuclear HeLa lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.](http://images.novusbio.com/fullsize/nbp1-28798_goat-polyclonal-ewsr1-antibody-imgenex-img-31193-12920231134474.jpg "Western Blot: EWSR1 Antibody [NBP1-28798] - (0.3ug/ml) staining of nuclear HeLa lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.")
![Immunohistochemistry-Paraffin: EWSR1 Antibody [NBP1-28798] - Negative Control showing staining of paraffin embedded Human Kidney, with no primary antibody.](http://images.novusbio.com/fullsize/nbp1-28798_goat-polyclonal-ewsr1-antibody-imgenex-img-31193-12920231134478.jpg)
![Immunohistochemistry-Paraffin: EWSR1 Antibody [NBP1-28798] - (7ug/ml) staining of paraffin embedded Human Kidney. Heat induced antigen retrieval with citrate buffer pH 6, HRP-staining.](http://images.novusbio.com/fullsize/nbp1-28798_goat-polyclonal-ewsr1-antibody-imgenex-img-31193-129202311344713.jpg)
![Western Blot: NKCC2/SLC12A1 Antibody [NBP1-57622] - Sample Tissue: Human A549 Antibody Dilution: 1.0 ug/ml](http://images.novusbio.com/fullsize/NKCC2-SLC12A1-Antibody-Western-Blot-NBP1-57622-img0007.jpg "Western Blot: NKCC2/SLC12A1 Antibody [NBP1-57622] - Sample Tissue: Human A549 Antibody Dilution: 1.0 ug/ml")
![Immunohistochemistry: NKCC2/SLC12A1 Antibody [NBP1-57622] - Paraffin Embedded Tissue: Human Kidney Cellular Data: Epithelial cells of renal tubule Antibody Concentration: 4.0 - 8.0 ug/ml Magnification: 400X](http://images.novusbio.com/fullsize/NKCC2-SLC12A1-Antibody-Immunohistochemistry-NBP1-57622-img0006.jpg)
![Western Blot: NKCC2/SLC12A1 Antibody [NBP1-57622] - Jurkat cell lysate, Antibody Titration: 0.2-1 ug/ml](http://images.novusbio.com/fullsize/NKCC2-SLC12A1-Antibody-Western-Blot-NBP1-57622-img0002.jpg)
![Western Blot: NKCC2/SLC12A1 Antibody [NBP1-57622] - Sample Tissue: Jurkat, Lane A: Primary Antibody, Lane B: Primary Antibody + Blocking Peptide, Primary Antibody Concentration: 1ug/ml, Peptide Concentration: 5ug/ml, Lysate Quantity: 25ug/lane/lane, Gel Concentration: 0.12](http://images.novusbio.com/fullsize/NKCC2-SLC12A1-Antibody-Western-Blot-NBP1-57622-img0005.jpg)